e-learning
resources
Vienna 2009
Sunday, 13.09.2009
New results in molecular pathology and functional genomics of non-neoplastic lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
A comparative proteomic profiling of the human erythrocyte membrane in COPD patients
C. Lopes, B. Alexandre, N. Charro, P. Azevedo, A. Bugalho-Almeida, K. Chan, H. Issaq, T. Veenstra, J. Blonder, D. Penque (Lisbon, Portugal; Frederick, United States Of America)
Source:
Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases
Session:
New results in molecular pathology and functional genomics of non-neoplastic lung diseases
Session type:
Thematic Poster Session
Number:
849
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Lopes, B. Alexandre, N. Charro, P. Azevedo, A. Bugalho-Almeida, K. Chan, H. Issaq, T. Veenstra, J. Blonder, D. Penque (Lisbon, Portugal; Frederick, United States Of America). A comparative proteomic profiling of the human erythrocyte membrane in COPD patients. Eur Respir J 2009; 34: Suppl. 53, 849
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
The physiology of breathlessness
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Transcriptome profiling of platelets from patients with severe asthma.
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Year: 2021
Combined genome-wide transcriptomic and epigenetic profiling across disease stages identifies novel regulators of COPD in human lung fibroblasts
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020
Metabolomic profiling differences among asthma, COPD and healthy controls: a LC-MS-based metabolomics analysis
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019
Comparative analysis of the plasma metabolomics in rodent models of pulmonary hypertension and patients with IPAH shows different metabolic signatures
Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench
Year: 2019
The landscape of transcriptomic and proteomic studies in sarcoidosis
Source: ERJ Open Res, 8 (1) 00621-2021; 10.1183/23120541.00621-2021
Year: 2022
Association between microbiome and plasma proteome profile in COPD
Source: Virtual Congress 2020 – Intercellular communication in tissue remodelling of chronic lung diseases
Year: 2020
Altered serum metabolomics in COPD: analysis of the SPIROMICS cohort
Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond
Year: 2018
A proteomic approach to the progression of COPD: protein expression profile in induced sputum samples
Source: Eur Respir J 2006; 28: Suppl. 50, 824s
Year: 2006
Novel method of expressing serum biomarkers profiling in COPD patients: The heatmap-clinical pattern profile
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010
Metabolomic fingerprinting in the identification of biomarkers in COPD patients
Source: Annual Congress 2012 - Basic and translational studies in COPD
Year: 2012
COPD phenotypes revealed by the integrated sputum microbiome and proteome analysis in COPDMAP cohort
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019
Alveolar macrophage transcriptomic profiling in COPD shows major lipid metabolism changes
Source: ERJ Open Res, 7 (3) 00915-2020; 10.1183/23120541.00915-2020
Year: 2021
Detailed physiological profiling of patients for a study investigating the airway microbiome
Source: International Congress 2018 – Innovations in equipment and their application
Year: 2018
iTRAQ-based proteomic analysis reveals mitochondrial 'damage'-associated molecular patterns are involved in pulmonary inflammation in Lypopolysaccharide-induced acute lung injury
Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury
Year: 2018
Serum microRNA signatures identified in a genome-wide profiling predict the mortality of patients with sepsis
Source: Annual Congress 2011 - New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections
Year: 2011
Plasma metabolomic signature in COPD patients: Associations to proteomic profile and clinical outcomes
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Identification of disease genes by expression profiling
Source: Eur Respir J 2001; 18: 882-889
Year: 2001
Proteomic and genomic profiling to identify pathogenic mechanisms of inflammation, proteolysis and wasting in a murine COPD model
Source: Eur Respir J 2004; 24: Suppl. 48, 104s
Year: 2004
Proteomic derived biomarkers for COPD are present in induced sputum
Source: Eur Respir J 2005; 26: Suppl. 49, 439s
Year: 2005
Training-induced effects on plasma metabolomics in patients with COPD
Source: Annual Congress 2008 - Discovery of novel targets in lung disease by means of functional genomics
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept